3DeWood MA, Spores J, Notske R, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med, 1980,303:897-902.
4Fletcher AP, Sherry S, Alkjaersig N, et al. The maintenance of a sustained thrombolytie state in man. II. Clinical observations on patients with myocardial infarction and other thromboembolic disorders. J Clin Invest, 1959,38: 1111-1119.
5Fassa AA, Urban P, Radovanovic D, et al. AMIS Plus Investigators. Trends in reperfusion therapy of ST segment elevation myocardial infarction in Switzerland: six year results from a nationwide registry. Heart, 2005, 91:882-888.
6Rogers WJ, Canto JG, Lambrew CT, et al. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. J Am Coll Cardiol, 2000, 36: 2056-2063.
7Fox KA, Goodman SG, Anderson FA Jr, et al. From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE). Eur heart J, 2003, 24:1414-1424.
8Fox KA, Cokkinos DV, Deckers J, et al. The ENACT study: a pan-European survey of acute coronary syndromes. European Network for Acute Coronary Treatment. Eur Heart J, 2000, 21 : 1440-1449.
9Hasdai D,Behar S, Wallentin L, et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes ( Euro Heart Survey ACS). Eur Heart J, 2002, 23:1190-1201.
10Chen ZM, Jiang LX, Chen YP, et al. Addition of clopidogrel to aspirin in 45, 852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet, 2005, 366: 1607-1621.
